Natalie S. Feldman, AB
- 2Articles
- 4.9KReads1
- 2012–2013Active
- 8Collaborators
- 26Citations2
About
Natalie S. Feldman, AB, has contributed to research on bipolar disorder, focusing on clinical trials involving ziprasidone monotherapy in patients with co-occurring anxiety disorders, as well as the impact of serious or undiagnosed medical conditions on clinical trial participation. Her work, published between 2012 and 2013 in Psychiatrist.com, addresses the complexities of treating bipolar disorder in the presence of comorbid conditions.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
